TREATMENT PATTERNS AND HEALTHCARE RESOURCE UTILIZATION IN RUXOLITINIB-TREATED PATIENTS WITH MYELOFIBROSIS WITH AND WITHOUT ANEMIA: A REAL-WORLD ANALYSIS

被引：0
|
作者：
Liu, T. [1 ]
Fillbrunn, M. [2 ]
Chen, J. [2 ]
Sajeev, G. [2 ]
Zhang, S. [3 ]
Signorovitch, J. [2 ]
机构：
[1] GSK plc, Philadelphia, PA USA
[2] Anal Grp Inc, Boston, MA USA
[3] GSK, Philadelphia, PA USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE407
引用
收藏
页码：S132 / S132
页数：1
相关论文
共 50 条
  • [1] Real-World Analysis of Ruxolitinib Treatment Patterns and Outcomes Among Patients with Myelofibrosis
    Burton, Tanya
    Parikh, Kejal
    Patel, Manish
    Sundquist, Kevin
    Lal, Lincy S.
    Copher, Ronda
    Gerds, Aaron T.
    BLOOD, 2019, 134
  • [2] Second primary malignancies in ruxolitinib-treated myelofibrosis: real-world evidence from 219 consecutive patients
    Maffioli, Margherita
    Giorgino, Toni
    Mora, Barbara
    Iurlo, Alessandra
    Elli, Elena
    Finazzi, Maria Chiara
    Caramella, Marianna
    Rumi, Elisa
    Carraro, Maria Cristina
    Polverelli, Nicola
    D'Adda, Mariella
    Malato, Simona
    Rossi, Marianna
    Molteni, Alfredo
    Vismara, Alessandro
    Sissa, Cinzia
    Spina, Francesco
    Anghilieri, Michela
    Cattaneo, Daniele
    Renso, Rossella
    Bellini, Marta
    Pioltelli, Maria Luisa
    Cavalloni, Chiara
    Barraco, Daniela
    Accetta, Raffaella
    Bertu, Lorenza
    Della Porta, Matteo Giovanni
    Passamonti, Francesco
    BLOOD ADVANCES, 2019, 3 (21) : 3196 - 3200
  • [3] Real-World Resource Utilization Patterns of Patients Treated With Cholangioscopy
    Pleskow, D.
    Cangelosi, M. J.
    Faucher, S.
    Stockwell, B.
    Khamamkar, V.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S952 - S952
  • [4] Real-World Ruxolitinib Treatment Pattern in Myelofibrosis Patients With Thrombocytopenia
    Kabir, Sujan
    Mei, Jian
    Wang, Yifei
    Ichikawa, Natsumi
    Ino, Suichi
    Lebedinsky, Claudia
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S336 - S337
  • [5] Real-World Utilization of Fedratinib for Myelofibrosis Post-Ruxolitinib: Patient Characteristics, Treatment Patterns, and Characterization of Ruxolitinib Failure
    Harrison, Claire N.
    Mascarenhas, John
    Abraham, Pranav
    Kee, Arianna
    Nadal, Jose Alberto
    Balanean, Alexandrina
    McBride, Ali
    Kish, Jonathan K.
    Liassou, Djibril
    Feinberg, Bruce A.
    Gerds, Aaron T.
    BLOOD, 2021, 138
  • [6] Real-world treatment patterns and healthcare resource utilization among migraine patients: a German claims database analysis
    Gaul, Charly
    Seidel, Karolin
    Heuck, Alexander
    Silaidos, Carmina
    Mrosowsky, Thora
    Eberhardt, Alice
    Fritz, Bjorn
    Jacob, Christian
    JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 667 - 678
  • [7] Real-World Outcome of Patients with Myelofibrosis Treated with Ruxolitinib in the West of Scotland: A Retrospective Multicentre Analysis
    Dikair, Abdalla
    Hopkins, David
    Rafferty, Mark
    Louden, Gail
    Drummond, Mark
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 197 : 78 - 78
  • [8] Meter: A Multi-Country, Real-World Chart Review Study to Explore Treatment Patterns, Effectiveness and Healthcare Resource Utilization for Patients with Myelofibrosis
    Gupta, Vikas
    Tomuleasa, Ciprian
    Barranco Lampon, Gilberto Israel
    Hou, Hsin-An
    Helbig, Grzegorz
    Symeonidis, Argiris S.
    Haznedaroglu, Ibrahim
    Galvez, Kenny
    Tatsch, Fernando
    Chopra, Avijeet S.
    Zhang, Meng
    Vizkelety, Tamas
    Ross, David M.
    BLOOD, 2023, 142
  • [9] Real-world Treatment Patterns, Outcomes, and Healthcare Resource Utilization in Newly Treated Korean Patients With Asthma: A Retrospective Cohort Study
    Choi, Nam-Kyong
    Shantakumar, Sumitra
    Kim, Mi-Sook
    Lee, Chang-Hoon
    Cheng, Wendy Y.
    Bobbili, Priyanka
    Yang, Bo Ram
    Lee, Joongyub
    Hinds, David
    Duh, Mei Sheng
    Korves, Caroline
    Park, Heung-Woo
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2022, 14 (02) : 220 - 232
  • [10] An Analysis of Ruxolitinib Dosing for Myelofibrosis in Real-World Practice
    Rossetti, James M.
    Choksi, Rushir
    Suthar, Purvi
    Davis, Phoebe
    Vasudevan, Anupama
    Dave, Poras
    Vaidya, Varun
    Wang, Brandon
    Katzen, Harvey I.
    BLOOD, 2023, 142
12345